| 0.7563 0.001 (0.19%) | 06-09 16:00 | |||||||||||||
|
|
| Short term | |
|||
| Mid term | |
|||
| Targets | 6-month : | 1.22 | 1-year : | 1.47 |
| Resists | First : | 1.04 | Second : | 1.25 |
| Pivot price | 0.94 |
|||
| Supports | First : | 0.7 | Second : | 0.58 |
| MAs | MA(5) : | 0.79 |
MA(20) : | 1 |
| MA(100) : | 1.13 |
MA(250) : | 2.16 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 10.9 |
D(3) : | 13.4 |
| RSI | RSI(14): 25.7 |
|||
| 52-week | High : | 9 | Low : | 0.7 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ LITS ] has closed above bottom band by 13.1%. Bollinger Bands are 122.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 7 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 0.79 - 0.8 | 0.8 - 0.8 |
| Low: | 0.72 - 0.72 | 0.72 - 0.72 |
| Close: | 0.75 - 0.76 | 0.76 - 0.76 |
Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San Diego, California.
Tue, 02 Jun 2026
MSN Money - MSN
Fri, 15 May 2026
Number of shareholders of Lite Strategy, Inc. – NASDAQ:LITS - TradingView
Wed, 13 May 2026
Lite Strategy Reports Fiscal 2026 Third Quarter Results - GlobeNewswire
Tue, 17 Feb 2026
Lite Strategy Reports Fiscal 2026 Second Quarter Results - GlobeNewswire
Wed, 24 Dec 2025
Have Lite Strategy Insiders Been Selling Stock? - simplywall.st
Mon, 17 Nov 2025
Lite Strategy becomes first US public company to hold Litecoin - Investing.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management - Cryptocurrency
|
|
| Shares Out | 34 (M) |
| Shares Float | 26 (M) |
| Held by Insiders | 11.9 (%) |
| Held by Institutions | 17.3 (%) |
| Shares Short | 77 (K) |
| Shares Short P.Month | 65 (K) |
| EPS | -2.08 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.23 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -27.7 % |
| Return on Equity (ttm) | -159.3 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | -0.06 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -0.51 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -10 (M) |
| Levered Free Cash Flow | -13 (M) |
| PE Ratio | -0.37 |
| PEG Ratio | 2.2 |
| Price to Book value | 0.33 |
| Price to Sales | 0 |
| Price to Cash Flow | -2.47 |
| Dividend | 1.75 |
| Forward Dividend | 0 |
| Dividend Yield | 231.3% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |